The basis for the increased sensitivity of AR-positive PCa to DOT1L inhibition appears to be the coregulation of MYC by DOT1L and AR at a distal enhancer active only in AR-positive PCa cells. This evidence concerns the gene MYC and posterior cortical atrophy.